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1 EXECUTIVE SUMMARY 
That there are workforce shortages in pathology is not a new finding1.  This is a healthcare 
system-wide problem. 
What has not been well recognised to date is the current impact of these shortages and the 
extent to which many of the mitigation strategies designed to improve productivity for the 
broader healthcare system have already been widely deployed in the pathology sector.   Further 
application of such strategies is therefore not likely to have the same impact for the pathology 
sector as they might elsewhere.   
Indeed, it was argued during consultation discussions that this past success in productivity 
improvement over the last two decades was a likely cause of the late recognition of the extent 
of the current problem. 
This report shows that it is clear that there is now a real problem with workforce shortages in 
pathology and the available projections infer a further and significant impact on service quality 
and timeliness if urgent action is not taken2.  
Because of the critical role that pathology plays in so many aspects of clinical decision making, 
impacts on pathology service quality and timeliness will have serious consequences for safety 
and efficiency in the whole health system. 
All those consulted agree that there are workforce shortages in all parts of the pathology 
workforce.   The critical shortages are best documented for specialist pathologists but there is 
also good evidence of a critical shortage of scientists.   All agree however that too little is 
known about the workforce to manage it properly, both as a whole or in its component parts. 
While the pathology workforce needs to be considered as part of any broader health workforce 
review, it cannot wait for any 'comprehensive industry-wide’ solution which, in any event, may 
be less appropriate to its needs. Those working in pathology believe that co-ordination at a 
national level is required. 
Mitigating strategies are proposed here that need to be considered and acted upon as they apply 
to the various workforce groups but there is an urgency for this action to occur which will in 
the first instance by necessity need to be aimed at maintenance.  It was argued that the window 
of opportunity for this is as short as eighteen months. 
The strategies outlined in this report are presented under the following framework, according to 
their focus and intent.  However, the headings included in the framework are not mutually 
exclusive and it is expected that multiple, related strategies will need to be adopted.  
                                                 
1 There have been reports on health workforce issues by the Productivity Commission on behalf of the Council of 
Australian Governments, by the National Health Workforce Taskforce (and before them the Australian Medical 
Workforce Advisory Committee) on behalf of the Australian Health Ministers Advisory Committee, by State 
Governments and from Colleges and Scientific Societies.  More than 15 such reports and submissions specific to 
pathology and its sub-disciplines are listed in Appendix B. 
2 A National Workshop on Quality and Safety in Pathology with around 50 participants held in November 2007 
identified workforce as a current critical problem and the greatest risk to quality and safety facing the pathology 
sector. 




The framework is as follows: 
• Increase the supply of workers by 
o Increasing the opportunities for education and training 
o Improving recruitment 
o Retaining the workforce longer 
o Attracting re-entry of those who have exited 
• Redistribute the workforce from areas of lower to higher demand 
o Geographically 
o By discipline 
• Improve the productivity of the workforce  by  
o Improving work design 
o The introduction of new technology 
o Further consolidation 
• Reduce the demand by 
o Improving the quality of ordering 
o Rationing 
The approach adopted will necessarily be different for different types of worker and for 
different places. 





2.1 Scope of this report 
Michael Legg and Associates was asked to ‘assist the Department to prepare a background 
discussion paper which sets out the scope and structure of the pathology industry workforce 
and draws together a summary of the key issues, gaps and opportunities for further work to be 
undertaken on this issue’ 
A series of consultations were undertaken including meetings in four states/territories.  The 
details of these are provided at Appendix A – Consultations undertaken. 
Relevant reports and submissions were identified and reviewed and submissions were invited 
from relevant organisations.  These are shown at Appendix B – Reports, papers and 
submissions 
2.2 Pathology 
Pathology is a medical specialty which focuses on understanding what causes disease and in 
making diagnoses. 
Pathology involves the examination and testing of body fluids (eg blood), body tissues and 
cells to identify what changes are occurring and to assist in selecting the best course of 
treatment.  It is the diagnostic skills of pathologists and their laboratory-based scientific 
colleagues that allow patients to know if they are pregnant, anaemic, diabetic, at risk of heart 
disease or if their lump is cancerous. 
Pathology plays a critical role in more than 70% of clinical diagnoses and many of the 
decisions around the optimal treatment for patients. 
Pathology is a scientific discipline and research has always been a cornerstone.  Many of the 
great advances in medicine such as antibiotics, vaccines, transfusions and transplants have been 
based on the work of pathologists.  Several internationally recognised Australian scientists, 
including two Nobel Prize winners, have done their prize-winning work in pathology-related 
research fields, such as immunology.  Pathology is now working directly at the rapidly 
advancing frontiers of genetics, including molecular biology, epigenetics and pre-emptive and 
personalised medicine.   
2.3 The current pathology work environment 
Whether owned by governments, non-profit organisations or shareholders, the pathology 
organisations and their laboratories in Australia are now quite similar in their structure and 
function.   
Three private national pathology organisations do around 80% of the community pathology in 
Australia and there is either just one or a few publicly-funded pathology networks in each State, 
which mostly service the public hospitals.  The actual volume split between public and private 
pathology is not known but has been estimated at 60% private and 40% public. 
While there are differences in emphasis in their caseload, with public pathology doing more 
hospital work and private pathology more community work, there are public laboratories that 
provide community services (to private practice GPs and specialists) just as there are private 




pathology practices that do complex hospital-based and specialist work (in some cases for 
public teaching hospitals).   
No laboratory in Australia can do all of the tests asked of it and there is a well established 
(although said to be under-remunerated) mechanism for referral both between laboratories and 
across sectors. 
Whether privately or publicly owned, most pathology services are provided in large centralised 
laboratories in capital cities.  These laboratories are associated with a network of smaller 
regional laboratories, often located within hospitals – both public and private. 
In addition, there are also more than a hundred boutique (mostly private) and niche research 
laboratories (mostly public) and a small but growing amount of pathology testing is done at the 
“Point of Care” rather than in laboratories.  In hospitals, for example, this point-of-care testing 
may be in the form of troponin level testing in the Emergency Department to check for 
indications of myocardial infarction (heart attack), the use in General Practice of INR testing 
for the management of anti-coagulant therapy, and for use by consumers/patients to check their 
blood glucose levels for diabetes. 
Hospital-based and comprehensive private laboratories are almost always 24 hour operations.  
For those working in the community sector, most activity occurs in the evening.   
Associated with the laboratory is generally a wide network of facilities for the collection of 
pathology specimens.  This includes a sophisticated, quality-assured logistics network for the 
safe transport of specimens between healthcare facilities (including general practice), collection 
centres, and laboratories. 
Larger pathology laboratories are broken up into departments that reflect the knowledge 
domains and sometimes the nature of the testing that is done.  These include:  
• Histopathology: examining organs, tissue and cells to decide if a disease is present and 
what effect it could have on the patient eg whether a breast lump is cancerous or not. 
• Cytopathology: the examination of small samples of cells to identify abnormalities, 
usually from a smear (eg a pap smear for cervical cancer), brushing technique (to 
collect skin cells) or fine needle aspiration (from a cyst). 
• Microbiology: the study of bacteria, fungi, parasites and viruses to examine, diagnose, 
treat and prevent the spread of infection. Outbreaks of food poisoning, meningitis or a 
virulent strain of flu would be investigated by a microbiology or virology laboratory.   
• Haematology: the study of blood cells in order to identify any abnormalities.  
Haematologists diagnose and treat a variety of blood disorders including anaemia, 
haemophilia and blood cancers, including leukaemia. 
• Immunopathology: focuses on disorders of the immune system and the body’s ability 
to resist invasion by foreign organisms. Immunologists play a key role in transplants 
and diseases like HIV-AIDS. 
• Blood Banking (Transfusion Medicine): combines haematology and immunology 
disciplines for testing compatibility and quality of donated blood 
• Chemical Pathology: the study of body fluids such as blood, urine, saliva or spinal 
fluid to detect abnormalities and make a diagnosis eg diabetes, high cholesterol and 
nutritional disorders. 




• Toxicology: the study of the effect of different substances on people, animals and the 
environment. Toxicologists can diagnose poisoning and help devise a treatment. They 
assess side effects of new medicines and determine safe doses.  
• Genetics and Cytogenetics: the examination of chromosomal and genetic 
abnormalities. This covers a range of issues such as prenatal diagnosis (eg Down’s 
syndrome), predictive testing for cancers and reactions to certain drugs. 
Clinical Pathology is a generic term that refers to chemical pathology, haematology, 
microbiology, blood banking and genetics/cytogenetics.  Anatomical Pathology is a term used 
to group histopathology, cytopathology and post mortem investigation.  
Many large laboratories now have a separate area for high-volume, rapid-turnaround testing 
which provides tests from the chemical pathology, microbiology and haematology disciplines. 
Smaller laboratories tend to do a limited range of tests that require rapid turn-around or special 
expertise. 
2.4 The current pathology workforce 
There is an often-held, but largely misguided, perception that pathology testing is all done by 
machines and that there is not much human involvement.  The average pathology service 
episode actually involves around one hour of worked time from a complex workforce 
team using a diverse range of skills. 
2.4.1 Types of pathology worker 
The pathology workforce consists of the following types of ‘worker’: 
• Specialist pathologists – are medical graduates with an additional five years specialist 
study and training to become expert in the use of laboratory tests to diagnose and treat 
disease.  In Australia, pathologists choose to train in one or more of the following 
disciplines: general, anatomical, chemical, clinical, forensic, genetics, haematology, 
immunopathology or microbiology.  There has been an increasing trend to even greater 
sub-specialisation, with general and clinical pathology not being popular options.  
Some, such as chemical pathologists, haematologists, immunopathologists and 
microbiologists, also work directly with patients and hold joint Fellowships with the 
Royal Australasian College of Physicians.  All pathologists have the role of interpreting 
the laboratory findings in clinical context. General pathologists are trained in all the 
disciplines and clinical pathologists in the clinical disciplines.  
• Medical scientists – are generally graduates with specific training in medical laboratory 
science and experience in testing in at least one of the disciplines of pathology.  Senior 
scientists often have additional post-graduate qualifications from universities and/or 
their scientific societies.  There are areas of pathology where scientists take a stronger 
leadership role than others – these are generally in the clinical (as opposed to 
anatomical) disciplines and the scientist can be the most expert in the team, especially in 
emerging areas such as genetics. Senior scientists provide much of the supervision and 
quality management in laboratories and are often recruited into laboratory management 
positions. 
• Health informaticians – ideally should be graduates specifically trained in health 
informatics – a discipline dealing with the collection, storage, retrieval, communication 
and optimal use of health related information and knowledge.  In practice, however, few 




                                                
have come via this route and most are either graduates in computer science or medical 
scientists that have learned on the job3.  Health informaticians are responsible for the 
safety, quality and development of the pathology information system and associated 
communications.   
• Technical officers or medical technicians – are workers with two years’ post-high 
school training to the Certificate IV or Associate Diploma levels.  Although they work 
under the direction of a Medical Scientist, they are able to do most routine work in the 
laboratory.   
• Laboratory assistants – generally have no relevant post-school training other than that 
provided in the work place.  They perform many of the non-analytical tasks within the 
laboratory that involve specimen handling including reception, preparation and 
transport within the laboratory.  They may load analysers but do not release results.  
• Collectors & nurses – collectors are mostly trained by pathology practices but many of 
these training programs are formal and accredited.  Some nurses also act as collectors 
but most are provided with the same training as for other collectors.  Some specific 
types of collections require that they be done by or with a registered nurse, such as 
autologous blood collection. Collectors take specimens which may be body fluids, 
scrapings or smears but mostly they collect venous blood. 
• Pathology couriers – are also workplace-trained and have a higher level of training and 
responsibility than do general carriers.  They transport specimens to the laboratory and 
reports (and other materials such as collection supplies) to healthcare facilities.  They 
are an important link in the chain of information custody and are responsible for 
biosecurity and the safe delivery of (often irreplaceable) specimens needed to make life 
and death decisions.  
• Clerical staff and others directly involved in testing – a category of worker that 
includes those with data entry and clerical training and for some, such as the medical 
typists, quite specific medical terminology training.  These workers are involved in 
areas such as specimen reception and request and result entry. 
• Management & support services – includes general and operations managers, 
accounts staff, human resources, engineers, stores and liaison staff. 
The National Pathology Accreditation Advisory Council (NPAAC) document “Requirements 
for the Supervision of Pathology Laboratories”4 includes definitions for a pathologist, a senior 
scientist and a scientist and describes expectations around staffing and requirements for the 
supervision of laboratories. 
 
3 There has been a push to introduce informatics as a pathology discipline in its own right (like haematology) but 
although this has progressed in the US and is starting in the UK it has not yet been adopted in Australia 
4 NPAAC Supervision Document 2007 




Only pathologists currently have a registration scheme, in the form of the State/Territory 
medical registration schemes.   Despite the fact that medical scientists are registered in other 
Western countries and the Australian Institute of Medical Scientists has called for their 
registration, the current COAG review of the registration of health professionals has not 
identified this as an area for attention.  This may in part be due to a lack of awareness of the 
extent of responsibility held for the production of high quality patient test results by scientific 
officers in partnership with specialist pathologists. 
 




2.4.2 Census, benchmarking, satisfaction and planning 
The 2006 Census5 revealed the following self-reported data for pathology-relevant occupations.   
 
  Males Females Persons 
   
234611 Medical Laboratory Scientist 4,340 9,029 13,369 
311213 Medical Laboratory Technician 2,107 9,569 11,676 
253915 Pathologist 584 571 1,155 
253313 Clinical Haematologist 39 30 69 
 Sub Total Pathology 7,070 19,199 26,269 
   
Total Health Workforce 136,676 456,172 592,848 
Proportion which is pathology 5% 4% 4% 
 
A typical laboratory might have the following profile of full time equivalents for the categories 












Around half of the staff in a comprehensive practice which includes regional laboratories work 
within the ‘biological testing zone’.  The rest are involved in the collection and transport of 
specimens and support of the organisation. 
A measure used by David Maister6 to gauge the efficiency of professional organisations is the 
ratio of professionals to others – so-called “leveraging”.  If pathologists alone are considered to 
be the professionals in this category then the “leverage” is 1:30.  If you include senior scientists 
it might drop to 1:10 but it is still very high by comparison to other health disciplines and other 
professions.  
A comparison of the ratios of pathologist category to others in the two data sets here suggests 
that there may be people other than pathology-related personnel ticking the Medical Laboratory 
Scientists and Medical Laboratory Technician box on the Census paper; or alternatively that 
people still consider themselves to be of that occupation even though they are not currently 
working in pathology.  Any survey undertaken would need to clearly differentiate between 
those involved in research and those in service roles. 
On the evidence it would be reasonable to state the number of persons working in the pathology 
sector is between 30,000 and 50,000.  This is more than 5% of the total health workforce.  At 
least 70% of the pathology workforce is female.
                                                 
5 ABS 2006 Census by health occupation Feb 2008 
6 A noted management consultant in professional organisations http://davidmaister.com/  




                                                
Work satisfaction and environment surveys have been undertaken both for scientists7 and 
pathologists8.  Reference is made to relevant results from those surveys in the sections that 
follow. 
The pathology workforce is not tracked by the Australian Institute of Health and Welfare as for 
other areas of healthcare in their biennial reports on Australia’s health9 but its future inclusion 
would improve monitoring options.  
There was some work on modelling the specialist pathologist workforce in 2002-03 by the 
Australian Medical Workforce Advisory Committee10. 
A survey was undertaken in 2007-08 by NPAAC11 of senior scientists and pathologists.  This 
work was undertaken for the purpose of establishing the availability of laboratory supervision 
capacity and because there were no other reliable sources of data available for that information. 
These survey results confirmed that there is a problem and provided some insights to its 
urgency.  Despite having only a 60% response rate, the results were checked by the relevant 
professional associations who considered that the data was likely to be a reasonable 
representation of the current situation.  This data is, however by its nature, a useful but 
incomplete snap shot and those consulted agreed that a more comprehensive and regularly 
updated set of data is required in order to manage the pathology workforce effectively on an 
ongoing basis. 
 
7 Charles Sturt Uni The professional status of medical scientists in Australia 2003 McGregor & Moriarty 
8 RCPA Work Environment Survey August 2007 
9 AIHW Australia's Health 2008, Chapter 8.2 Workforce 
10 AMWAC The Specialist Pathology Workforce in Australia - Supply and Requirements 2003-2013 - 2003 
11 NPAAC Pathology Workforce Census 2007 (with around a 60% response rate) 
12 Pathologists July 2008 




Data on the breakdown by discipline for pathologists and senior scientists from the NPAAC 











Data on the age of pathologists and senior scientists from the NPAAC survey is shown 











A model was established by the NPAAC working group to test workforce projections 
for pathologists and senior scientists.  The results of that model are shown graphically 
below.  The number of workers is plotted against years from 2007 to 2032 by five year 
steps.  Baseline is what would happen if there was no change to today’s processes.  The 
lines marked as +x% show the growth in numbers if there could be an x% compound 
growth in net entry.  The dotted lines show required numbers assuming the present 











2.5 The current education and training environment 
A brief overview of the current education and training arrangements for the sector is provided 
below.  
2.5.1 Colleges, Societies and Associations 
In addition to education institutions, at least 16 other organisations have a role of representing 
and educating members of the pathology workforce.  They include: 
• Specialist Colleges 
o Royal College of Pathologists of Australasia (RCPA) 
o Royal Australasian College of Physicians (for dually qualified Fellows) 
• Scientific Societies and Associations 
o Australasian Association of Clinical Biochemists (AACB) 
o Australian Institute of Medical Scientists (AIMS) 
o Australian Society of Cytology (ASC) 
o Australian Society for Microbiology (ASM) 
o Australian New Zealand Society of Blood Transfusion (ANZSBT) 
o Australasian Society of Clinical Immunology and Allergy (ASCIA) 
o Haematology Society of Australia and New Zealand (HSANZ) 
o Health Informatics Society of Australia (HISA) 
o Human Genetics Society of Australia (HGSA) 
o International Academy of Pathology, Australasian Division (IAP) 
o Public Health Association (PHA) 
• Industry Associations 
o Australian Association of Pathology Practices (AAPP) - Non-government, 
private sector pathology practice members 
o National Coalition of Public Pathology (NCOPP) – Government-owned 
pathology practice members 
o Pathology Associations Committee – a forum made up of most of the above 
groups, with the secretariat function undertaken by the RCPA 
o Australian Hospital and Healthcare Association (AHHA) – Public hospitals  
2.5.2 Education Institutions 
Education programmes relevant to the pathology workforce are offered by Universities, 
Institutes of Technology, TAFE Colleges, through accredited education courses conducted by 
pathology organisations and through on-the-job training.   
An overview of these programmes is provided by work category in the following sections.  
Pathologists 
In line with the model which occurs in most other medical specialty fields, the RCPA and its 
Fellows support the training of medical graduates toward a Fellowship in pathology.  Those 
trainees mostly derive from the 18 medical schools in Australia.  Of these, most now run 
graduate entry programs.  The output from medical schools is expected to almost double from 
2010. 
As noted above, in Australia pathologists choose to train in one or more disciplines over a five 
year post-graduate training period.  With increasing complexity in scientific knowledge, there 
is a trend to even greater sub-specialisation, and general and clinical pathology have become 
less popular options.   




The training program involves both academic learning, including Part I and II examinations, 
and on-the-job training and adequate specialist supervision is a critical element in this training 
process.   
The RCPA is involved in credentialing overseas trained pathologists and has actively refined its 
assessment processes so as to facilitate entry to the Australian workforce where appropriate. 
The RCPA expects around 70 to sit their Part II examinations in 2008 and then, providing that 
training time is completed and the exams passed, they will graduate pathologists in the mix 
shown in the table below. 
 
Discipline Number Sitting Part 
II Exam 2008 
Chemical Pathology 4 
Microbiology 14 
Immunopathology 7 
Forensic Pathology 2 
Haematology 23 
Genetics 1 
Anatomical Pathology 30 
 
Medical Scientists 
The Australian Institute of Medical Scientists (AIMS) has the role of accrediting bachelor 
degree programs in medical laboratory science in Australia.  These are at James Cook 
University and QUT in Queensland, University of Technology, Sydney and Charles Sturt 
University in New South Wales, RMIT University in Victoria, University of Tasmania, 
University of South Australia and Curtin University of Technology in Western Australia. 
An example of undergraduate, postgraduate and research pathways is provided by RMIT 
University12
Fellowships and other post-graduate qualifications in specific areas of laboratory medicine are 
offered to scientists by the AACB, AIMS, ASC, ASM and HGSA.  RCPA currently offers 
Associate membership for senior scientists and is examining the possibility of providing a full 
Fellowship option in the near future. 
Between 220 and 240 students are expected to graduate from AIMS accredited courses in 2008.  
Of these, between 80% and 95% can be expected to enter the medical science workforce; some 
of the remainder will go on to other studies, many into medicine. 
AIMS is also the assessing authority for overseas-trained laboratory scientists under the 
General Skilled Migration program.  
                                                 
12 RMIT Laboratory Medicine pathways 2008 




Technical Officers and Medical Technicians  
This is the group for which there is greatest variation in the training that is being offered and 
indeed what the job is called and what is expected of the worker. 
In most cases it requires two years’ post high school training to the Certificate IV or Associate 
Diploma levels which is provided by TAFE Colleges or Institutes of Technology. 
There is an issue with high variability in the quality of TAFE offerings for technicians. 
Laboratory Assistants 
Laboratory assistants require no relevant post-school training other than that provided in the 
work place. 
Health Informaticians 
Courses have been available at the undergraduate and graduate levels but a number of the 
courses have closed in recent times and none have been specific to pathology.  Sydney 
University and LaTrobe University continue to offer programs.  On-line education is being 
developed internationally and the Health Informatics Society of Australia is establishing a 
voluntary registration system for this group of professionals. 
The Australian Computer Society accredits health informatics courses in Australia because of 
their historical association with information technology departments. 
Collectors & Nurses 
Collectors are mostly trained by pathology practices but many of these training programs are 
formal and accredited.  Some nurses also act as collectors but they are generally still provided 
the same training as for other collectors. 
Others 
The rest are not specific to pathology and have a myriad of options for formal and on the job 
training. 
2.6 A comparison with the broader health workforce 
That the needs of the pathology sector are not currently being recognised in the larger health 
workforce review activities is an issue identified in consultation.   
There is speculation that this is because the pathology workforce is small by comparison (at 
around 5%) and that there has not yet been a trigger to focus that attention, like media-
attracting incidents related to quality or service levels, as there has been in other parts of the 
acute care sector.  This, however, has started to occur, for example, in Canada where the 
pathology workforce shortages have reached a critical point. 
 The Productivity Commission, in their report13 on Australia’s health workforce, identified the 
following systemic problems: 
2.6.1  Productivity Commission Report  
• Fragmented roles and responsibilities, with health workforce policy 
‘compartmentalised’ by profession, even in circumstances when an integrated ‘cross-
profession’ approach is clearly called for 
                                                 
13 COAG Productivity Commission 2005, Australia’s Health Workforce, Final report, Canberra 




• Inadequate co-ordination mechanisms, inflexible and inconsistent regulation with a lack 
of collaborative policy efforts to improve co-ordination across the various parts of the 
system 
• Inflexible and inconsistent regulation that is subject to considerable influence from the 
professional groups concerned, and widely perceived as inhibiting changes to scopes of 
practice and the development of new competencies that could help to better meet 
changing health care needs 
• Perverse funding and payments incentives that may result in patients seeking treatment 
from a doctor, when (unsubsidised) treatment from another health professional may be 
more appropriate and limited incentives for medical practitioners to delegate less 
complex service provision to other suitable skilled but more cost-effective, health 
professionals; 
• Entrenched workforce behaviours that are heavily influenced by ‘custom and practice' 
As will be seen from what follows, these themes and the associated mitigation strategies are 
probably more applicable to other parts of the health care system than to the pathology sector.  
This is largely because the pathology sector has undergone a process of structural review over 
the past twenty years or more, and many of the strategies outlined in the response by COAG 
(shown below) are already under consideration and/or in place.  This is not to say that there is 
not more that could be done and consultation undertaken to date has revealed a strong stated 
desire on the part of the sector to engage with governments to make further progress. 
2.6.2 COAG Response to the Productivity Commission Report 
• Reduce health workforce shortages through significant investments, including 
additional medical school and higher education nursing places and capital funding for 
medical schools and nurses’ clinical training. The increase in medical school places 
would result in an expansion in the number of medical school places bonded to areas of 
workforce shortage 
• Promote workforce mobility and consistency between jurisdictions by creating national 
registration and accreditation schemes for health professions 
• Provide greater health service access for rural, remote and indigenous communities by 
introducing a new Medicare item for practice nurses and registered Aboriginal health 
workers to provide ongoing support for patients with chronic disease 
• Help medical specialist trainees build appropriate skills and experience by providing a 
new system of training rotations through an expanded range of settings beyond 
traditional public teaching hospitals, including regional, rural and ambulatory settings, 
private sector hospitals and practices and community settings 
• Create a national health workforce taskforce to undertake workforce projects and advise 
governments on workforce innovations and reforms. 
Additional relevant and targeted policy options to address outstanding areas for attention in 
relation to the pathology workforce are provided for consideration in the last section of this 
report. 




2.7 The regulatory environment in pathology 
Pathology has led the way amongst medical domains in that it has a formal and compulsory 
inspection and accreditation process with standards that are highly codified.   
Standards for pathology laboratory organisational systems are developed and published by the 
National Pathology Accreditation Advisory Council (NPAAC), in a unique arrangement which 
includes Commonwealth and State/Territory governments, medical and scientific professional 
groups, relevant industry representatives, and consumers.  NATA (The National Association of 
Testing Authorities) and the RCPA Quality Assurance Program together provide an assessment 
service that audits laboratories against the NPAAC standards.  A combination of NATA and 
RCPA QAP assessments lead to the accreditation of laboratories in specific areas of operation 
if the relevant standards have been assessed as met.  
The NPAAC standards identify requirements for performance against technical standards. 
These technical standards cover methods including clear linkage to reference methods (often 
established by the scientific societies), units and the requirements for external proficiency 
testing (Quality Assurance).   
NPAAC standards also, however, embrace by reference such things as building codes and 
safety standards, including infection control, ergonomics, lighting, biological waste and 
environmental emissions such as radiation.   
The NATA/RCPA assessment also looks at the pathology laboratory’s own internal procedures 
and work instructions. 
This accreditation status, combined with formal undertakings from the laboratory owners and 
the pathologists, is required before Medicare benefits can be paid for services in the Medicare 
Pathology Services Table.  The Medicare Services Advisory Committee (MSAC) makes 
recommendations to the Minister for new services to be added to the Schedule only on the basis 
of established safety, effectiveness and cost effectiveness. 
There are also NPAAC standards defining the training and competence required for technical 
and medical personnel for the purposes of ensuring adequate professional supervision of 
testing.  The RCPA arranges training and examine medical practitioners in the specialty of 
pathology.  The RCPA is assessed for its training competence by the Australian Medical 
Council.  Universities, TAFE, and various scientific societies provide training and examination 
for scientific and technical staff according to the criteria of the Australian National Training 
Authority. 
Some laboratories also voluntarily subject themselves to further auditing against other 
international standards for example ISO 9000 – Quality Systems and/or the Business 
Excellence Framework.   
Pathology laboratories that service hospitals and other healthcare institutions are also required 
to demonstrate service levels in accordance with the institution’s accreditation systems, such as 
ACHS’s EQuIP program. 
The adoption of international standards (ISO) has changed the focus from seeing laboratories as 
systems (ISO Guide 25, ISO 17025) to identifying that staff have key roles in the production of 
quality results (ISO 15189). This change is apparent in the requirements of ISO 15189 which 
require laboratories to have regular, documented competence testing of staff, to provide 
continuing education and for staff to have appropriate continuing professional development 
programs. 




The pathology professions and industry have also participated in a model of joint governance 
with successive Australian governments since the early 1990s.  These discussions have 
occurred largely in the context of the Pathology Consultative Committee (PCC), a peak 
advisory group comprised of the Australian Government, the Royal College of Pathologists in 
Australasia, the Australian Association of Pathology Practices and the National Coalition of 
Public Pathology.  Much or most national pathology policy developed during this period, 
especially that related to Medicare expenditure, has been significantly influenced by consensus 
reached through this group.  The PCC, in conjunction with its sub-committee the Quality Use 
of Pathology Committee, also oversees the Quality Use of Pathology Program, the aim of 
which is to identify, explore and evaluate opportunities to improve the practice, use and benefit 
of pathology testing.  
2.8 A comparison with peer countries 
The quality of pathology services provided in Australia has a good reputation, both nationally 
and internationally, and is generally considered to be world class. It may be of interest to note, 
for example, that the next international meeting of pathology colleges will be held in Sydney in 
early 2009. 
The issues relating to workforce identified in this paper have also been experienced by other 
countries that are commonly used for comparison such as New Zealand, the US and Canada.  
Taking Canada as the example – there has been headline news because of what appears to be a 
major failure in quality, with workforce shortage being identified as a major contributing 
factor. 
Australia, because of its comprehensive quality and accreditation system, has been somewhat 
protected from the kinds of incidents happening now in Canada.  Many countries have 
observed and drawn on the system for laboratory accreditation that was established co-
operatively here in Australia 
 The UK has recently initiated a total review of their health workforce and how structures 
within the NHS would work better. This has included definitions of competencies and the 
development of borderless training frameworks, with dedicated, centralised funding (to the tune 
of £4 billion) for training in the medical science-related fields so that training positions can be 
supported where there is an identified need and the capacity to support them. 
The operating model used by the largest Australian private pathology practice has also been 
proved internationally, with successful operations now in place in the UK, Germany, New 
Zealand and the US. 





3.1  Demographic change 
The strongest of the drivers leading to workforce shortage is demography and in particular the 
impact of the “baby boomer” birth-rate bulge reaching retirement age.  When this is combined 
with increased life expectancy, there is a double impact for healthcare – a reducing supply of 
workers with an increasing demand for services. 
Pathology as a component of the healthcare sector faces these general trends. Succinctly put: 
• Healthcare workforce supply is going down14 because 
o workforce entry is going down because 
 there is a reduced birth rate which is below replacement 
 generation Y (now 16-31 years old) are uncommitted to the same construct 
of career as previous generations and will inherit baby boomer wealth 
 there is a reduction in the understanding and prestige of science 
 there is competition for workers especially from boom sectors outside health 
o workforce exit is going up because 
 the workforce is ageing and large numbers are due for retirement in the near 
future  
 there is a feminisation of the workforce with more time taken out for a range 
of reasons (often family-related) 
 there is an increasing reduction in commitment to full-time work (and 
particularly long hours of work) by both men and women 
 there is competition for workers 
o BUT the workforce is also maldistributed because 
 professionals want to live in the affluent parts of cities 
 healthcare training has been done in the cities and trainees remain there 
 specialists are well settled and committed by the time they qualify at around 
41 years of age 
• healthcare demand is up because 
o people are living longer15 leading to 
 more disease prevalence 
 proportionately more complex diseases like cancers and dementia 
 more co-morbidities 
o more can be done in health care 
 with advances in diagnostic and therapeutic technologies such as better 
prostheses and surgical interventions 
 an explosion in the understanding of molecular pathology and the potential 
for personalised medicine 
o consumer expectations have increased 
 healthcare rationing is not considered acceptable – “no expense will be 
spared on the care of my loved ones” 
 service expectation is higher on the part of “baby boomers” 
o BUT the capacity of government to pay is going to reduce because 
 there are fewer workers to pay tax and drive gross domestic product. 
                                                 
14  It was reported that the workforce15-64 years will halve in 10 years 
15  It was reported that those over 65 will double in 10 years 




Data for the pathology sector and qualitative evidence from the consultations for this paper 
suggest that these trends are happening sooner for pathology and that they are more severe 
because they are being compounded by other more specific sector issues.  These issues are 
considered in more detail in Section 4 - Problems. 
3.2 Technology and medical advances  
Technology has had a marked impact on the pathology sector16 and consequently on its 
workforce.  The future promises even more likelihood of change although this change is more 
likely to occur in relation to doing new things rather than doing existing things faster, which 
has been a feature of progress in the last three decades. Considerations include: 
• Automation within the laboratory and the use of electronic decision support has 
changed the processes within the pathology laboratory, the roles of workers and the 
quality of analysis. 
• The development of instruments capable of being used at the point of care which, while 
there are some issues around cost and quality now, are being progressively adopted and 
may change where high volume and/or time-critical testing is done and by whom in the 
future. 
• Digital microscopy has now progressed to a stage where histological slides can be 
scanned at up to 50 levels of depth automatically, allowing a computer screen to be used 
for microscopy.  While currently still expensive and slow, this will improve and means 
that the ‘reading’ of slides can be done anywhere, allowing for distribution of the 
workforce, workload balancing and/or for special expertise to be drawn on where 
necessary.  The next advance, which is in the research phase now, is the introduction of 
image-based decision support.  It is likely to be ten years, however, before these 
technologies are ready to improve the productivity of anatomical pathologists to any 
extent. 
• The burgeoning understanding of biology and the rapid development of molecular 
biology and epigenetics, allowing for pre-emptive and personalised medicine.  For 
example, from a limited base there has been an explosion in the knowledge around 
common diseases in the last two years and much of this testing will form part of 
mainstream practice within five years. 
• The capacity to trap and identify blood-born cells from solid tumours such as breast and 
colon has been demonstrated in research.  The commercialisation of this technology 
may well have a significant impact on the use of histopathology 
• Other medical advances, such as the introduction of the cervical cancer vaccine 
(Gardasil) in 2007 to all 12 year old girls nationwide as part of the school immunisation 
programme, may well reduce or at least alter demand for Pap tests in the next 10 years. 
New technologies such as automated screening (using liquid based cytology samples 
and an imager) promise better performance.  The ThinPrep imaging system is before 
MSAC now and a result is expected in November 2008.  
3.3 Efficiency  
Whether driven by necessity because of cost pressure with rising volume or because of 
competition, there has been a marked and continuous increase in efficiency in the pathology 
sector for the whole of the last three decades of technological advancement.  This has not just 
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been because of automation – there has also been significant consolidation, work substitution 
and process engineering undertaken as part of a significant program of structural reform in the 
industry.  
Historically there has been an average increase in volume of testing of around 8% per annum 
without a matching rise in funding.  This, the industry reports, has resulted in a twenty five year 
“efficiency” dividend. 
There is a perception that there has been a long and continuous drive for efficiency in the 
pathology sector, which has not been matched in other areas of medicine in Australia.  The 
effect of this restraint has been exacerbated by the introduction of new tests into common 
clinical practice before the sometimes lengthy process of funding has been determined. 
3.4 Demand 
The demand for pathology is expected to rise and is being driven by matters including: 
• Increased disease prevalence and complexity with ageing population 
• Increased cancer prevalence with increased longevity 
• Increased emphasis on evidence based medicine that requires pathology for decision 
making 
• Increased use of pathology testing for eligibility for subsidised drug therapy and 
monitoring  
• Increased genetics (epigenetic and molecular pathology) testing for pre-emptive and 
personalised medicine 
• Increased consumer expectation that testing is part of diagnosis and treatment. 
3.5 Partisan mutual adjustment 
The consultations also revealed a widely held perception that pathology had declined in its 
prestige and capacity to win funding against other medical disciplines where “partisan mutual 
adjustment” is the norm in the resource-limited environment of healthcare. 
Reasons offered for this include: 
• The limited actual contact between pathologists and their patients 
• A reduction in clinical emphasis on the science of medicine, including significant 
reduction in pathology content in medical training, with a consequent underestimation 
of the value of the contribution made by pathology testing 
• The erroneous perception by the users of pathology and their patients that pathology is a 
machine-based discipline with little human involvement or expertise required 
• Lack of promotion of the value of pathology by the pathology profession themselves 
• Competition within the industry and the high service levels offered by pathology 
practices to requesters and consumers 
• The “commoditisation” of pathology, particularly in the hospital environment, where it 
has been sometimes grouped and dealt with in the same way as support services such as 
laundry and catering. 
 





4.1 All agree there is an immediate problem! 
No-one spoken to in the consultations believes that there is not an immediate problem with 
workforce shortage in pathology, nor did anyone suggest that it will not be a much bigger 
problem if action is not taken soon. 
All those consulted agree that there are workforce shortages in all parts of the pathology 
workforce.   The critical shortages are best documented for specialist pathologists but there is 
also good evidence of a critical shortage of scientists.    
All also agree that too little is known about the workforce as a whole, or in its component parts, 
to manage it properly. 
4.1.1  Medical Scientists 
AIMS writes: “It is generally accepted that there is a significant shortage of medical scientists 
in Australia, and that this shortage is particularly acute in rural and remote areas and is 
exacerbated by the ageing of the medical science workforce”.  A recent estimate indicated that 
more than 50% of Senior Scientists (using the National Pathology Accreditation Advisory 
Council definition) are aged 50 or over.  
The exact extent and severity of the shortage of medical scientist is not known: in fact, we do 
not know how many medical scientists are employed in Australian laboratories nor do we know 
how many unfilled vacancies exist. A detailed survey to determine the numbers, sex, ages, 
geographical distribution, educational levels, employment levels and other essential 
information must be a priority, and should be undertaken at the earliest opportunity Without 
these data any study of the pathology workforce will be severely limited” (AIMS, 2008). 
4.1.2 Pathologists 
The RCPA reports that “over the last 10 years in Australia, at least 70 training positions have 
been cut out of the system by stressed health administrators trying to balance budgets for the 
short term. There was seen to be no imperative to plan for the longer term. There are currently 
1,290 pathologists in active practice in Australia and 20% of these are over the age of 60. 130 
are over the age of 65. Currently in Australia, only approximately 70 new pathologists are 
produced each year on the funding made available by governments. This is quite frightening 
considering the age profile of pathologists and the fact that there are more than 70 vacancies in 
the system for qualified pathologists that cannot be filled.” 
Further, the AMWAC Report17 concluded that 500 additional trainee pathologist positions were 
needed by 2008 but only 100 have been funded to date.  
4.1.3 Other workers 
For other workers in pathology the workforce shortage, while real, appears to be more like the 
generic workforce shortages experienced across healthcare.  This is particularly a problem in 
those States that have boom industries such as mining where there is strong competition for the 
same workers. 
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4.1.4 Current signs of shortage 
Signs that the pathology workforce shortage is having an impact now include: 
• vacant positions 
• inability to attract appropriate applicants to advertised positions 
• additional training required of applicants (especially scientists) because they are not 
ready 
• unable to provide holiday cover for sub-specialists 
• closure of facilities such as the cancer care centre in Albury as a result of the retirement 
of pathologists, which meant correlation could not be done 
• long delays in reports especially in disciplines such as genetics and forensics (where it 
has changed the use of the testing and also caused closures of facilities in NSW) 
• a decline in service levels such as examples of the reduced number of courier runs in 
some public sector laboratories, leading to longer turn-around times for results 
• staff are now being flown in on a rotating basis from capital cities to some regional 
laboratories where they were once staffed locally, leading to a significant increase in 
operating costs 
• complaints from pathologists and scientists of excessive workloads. 
4.2   Specific pathology workforce issues 
4.2.1 Common 
The issues specific to pathology but common to all pathology workforce groups include: 
• a lack of understanding and profile of what pathology is and its value and so a lower 
standing in the community and the healthcare sector 
• the option of increasing supply by the use of overseas-trained pathologists and scientists 
is hampered by a world-wide shortage of well trained personnel, especially in the sub 
specialties with greatest need such as toxicology 
• there is an argument that laboratories are not being used optimally by requesters and 
that fewer more appropriate requests would result – however, this is balanced against 
the evidence that if protocols for common diseases (such as diabetes) were being 
adhered to, many more pathology tests would be ordered (double the number of HbA1c 
tests for diabetics for example) 
• the opportunity to further remodel the workforce is said to be impaired by some of the 
existing work practices, award structures and regulations. 
4.2.2 Medical Scientists 
In 2003 Louise McGregor and Helen Moriarty from Charles Sturt University conducted a 
survey of the professional status of medical scientists in Australia and established that the 
respondents perceived themselves and the profession to have low recognition, respect and 
professional autonomy, lack of opportunities for advancements, low autonomy and poor pay. 
When asked to rate their satisfaction with their pay, only 2% of the 500 respondents were very 
satisfied, with a further 10% moderately satisfied. 




The issues specific to medical scientists include: 
• Difficulty in attracting new recruits of appropriate quality because: 
o pay is not competitive - graduates of medical science degrees are poorly paid in 
comparison with graduates of other courses and in comparison with unskilled 
workers in some industries 
o there is little or no apparent career structure  
o the hours of work are unsociable  
o suitable education is not available eg cytopathology majors are only offered at 
UniSA (SA), RMIT (VIC) and Curtin UT (WA) – the cost of medical scientist 
training is high and so not attractive to universities 
o misleading advice is provided by universities about the appropriateness of 
certain general biomedical courses as training for work in pathology 
o some courses have an insufficient vocational component and one reason for this 
is that there are too few placements in laboratories 
o industry/employer need and course content have not always been aligned  
o undergraduate medical science degrees are often now used for entry to 
postgraduate medical education. 
• Difficulty in retaining staff because: 
o career progression is not facilitated – AIMS writes “graduates are routinely 
employed at a technical level: after that, it is the lack of progression that is 
particularly irksome and many scientists move from one laboratory to another 
trying to get up the ladder or just leave for another occupation” 
o career progression for senior scientist is toward a management rather than 
technical position and so those with knowledge and skills are lost from the 
service function 
o high proportion of females in the medical science workforce - women who leave 
the workforce to start a family may not return to the profession, or may return on 
a very limited part-time basis 
o high levels of responsibility without recognition of knowledge and skills (that 
might come from registration) 
o low levels of autonomy 
o the work environment is often stressed with continuous driving for efficiency 
gains 
o the public sector laboratories report being starved of capital and so there is a 
perception of not being at the cutting edge or indeed doing the job best 
o pay is not competitive and higher paid overseas positions are available that are 
more attractive 
o retirement becomes more attractive in the light of the issues outlined above. 
• Difficulty in re-entry to the workforce because: 
o the knowledge domain and technology is rapidly developing and the opportunity 
for bridging or upgrading courses are limited  





The issues specific to pathologists are different to those of scientists and include that: 
• there are too few trainee pathologists because there are too few funded trainee positions  
– the College maintains that there are interested medical graduates and that there are 
those willing and able to train but that there are not the training positions available to 
allow uptake of the traineeships – training is less than 80% of what is needed 
• reduced exposure to pathology in medical training and the associated loss of role 
models is reducing the attraction of the profession and consequently the calibre of 
trainee 
• the current rate of advance of knowledge in pathology makes it difficult to keep pace, 
especially in the sub-specialties and this is exacerbated when demands on service 
provision are high 
• work-load has got to a level where many pathologists are expressing concerns about the 
impact on quality and their unwillingness to sustain current workloads 
• issues around professional isolation of pathologists working in regional laboratories 
• the number training as general pathologists has declined – these pathologists are often 
well suited to regional laboratories in terms of being able to liaise with the local medical 
teams but there is a concern that by taking this route, a pathologist takes a career ‘dead-
end’ – “jack of all trades but master of none” in a field of increasing complexity 
• where pathologists have dual training for example in haematology the tendency is for 
most time to be spent in clinical practice reducing the availability of these pathologists 
for laboratory work  
• there are specific shortages in the sub-specialties now, including: 





o genetics and cytogenetics 
o immunopathology. 
4.3 The consequences of inaction 
There is a real concern that the high standards of quality in Australia are under threat by 
workforce shortages.  This was voted the number one risk in a recent workshop of some 50 
senior people on quality in pathology18. 
When asked what would happen if there was no improvement in shortages in the near future, 
the following were offered as likely outcomes: 
• The time taken to provide a pathology report will increase especially in the anatomical 
pathology and genetics disciplines resulting in 
o compromised care and increased risk to the patient 
o increased patient anxiety 
o reduced efficiency in hospitals including access block and extended stays 
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• Workers will be further stressed leading to 
o an exacerbation of all of the previously identified issues 
o reduced maintenance of skills and knowledge because there is no time to 
‘sharpen the saw’ 
• Increase in the cost of laboratory operations from  
o wages pressure 
o payment of overtime and contractors 
o fly-in fly-out arrangements in regional laboratories 
• Increase in costs of dependent services from 
o Emergency Department access block 
o increased length of hospital stay 
o use of more expensive substitutes such as point of care tests 
o increased waste with inappropriate treatment 
• Reduced capacity to teach, exacerbating the training shortfall 
• Reduced attractiveness of sector and so further loss of recruits to competition 
• Miss out on medical advances because of the dominance of the urgent routine work 
because there is  
o no time for working up new tests in the laboratory 
o no time for research 
o no time for MSAC submissions 
• Compromised care and increased risk to the patient from 
o Increased error rates in pathology results  
o Increased length of hospital stay and exposure to infection 
o Inappropriate, delayed or uncontrolled treatment 
• Limit the adoption of evidence based medicine and the associated lost opportunity cost, 
both financial and social. 
The experience in other countries such as Canada and New Zealand in recent time shows that 
these scenarios are not idle conjecture. 
The timeframe of demographic change and effect of the impending retirement of the baby 
boomer generation means that there is a very narrow window of opportunity to commence 
making the significant structural changes required to mitigate the existing and worsening 
workforce shortages in the pathology sector.  That window has been suggested by a leader of a 
State Health department (who is also a pathologist) to be as short as 18 months. 
 





As the Productivity Commission described it for healthcare in general, the aim for pathology is 
to have a more sustainable and responsive health workforce, while maintaining a commitment 
to high quality and safe health outcomes. 
The ways to address the problems with workforce shortage can be considered in the following 
framework (the elements of which are not mutually exclusive):  
• Increase the supply of workers by  
o Improving the image of pathology 
o Increasing the opportunities for education and training 
o Improving recruitment 
o Retaining the workforce longer 
o Attracting re-entry of those who have exited 
• Redistribute the workforce from areas of lower to higher demand 
o Geographically 
o By discipline 
• Improve the productivity of the workforce by  
o Improving work design 
o Further consolidation 
o The introduction of new technology 
• Reduce the demand by 
o Improving the quality of ordering 
o Rationing 
A number of innovations and activities were identified during the consultation phase.  These 
and other suggestions are described in the sections that follow, using the strategic framework 
outlined above. 
5.1  Increase the supply of workers 
There is a clear need for better information about the pathology workforce and better matching 
of training to the workplace. 
This data is needed on an ongoing basis in order to effectively manage the workforce into the 
future.  Those consulted believe that this management needs to be co-ordinated at a national 
level but there was no clear consensus on the mechanism that should be adopted.   
The following strategies were suggested: 
• Conduct a full workforce and workload audit 
• Seek inclusion of pathology-related workforce data in the AIHW two yearly reports 
• Increase the profile of pathology in the national health-workforce review activities 
5.1.1 Improve the image of pathology 
It seems clear from the consultation that the image of pathology needs to be addressed and the 
following are possible ways of doing that: 
• Continue and accelerate the work done by the College, and more recently by the 
Pathology Associations Committee, with programs like ‘National Pathology Week’, 
PathWay magazine, Careers Days for students and initiatives like ‘Labs are Vital’  




• Lobbying for a greater share of medical course time so as to increase students’ 
awareness and understanding of pathology testing and its place in the diagnostic process 
• Engage PCC members and their suppliers in an industry-wide program 
• Co-ordinate activities through the Pathology Associations Committee to increase the 
impact and maximise the ‘bang for buck’ 
5.1.2 Increase the opportunities for education and training 
Medical Scientists and Technicians 
Possible approaches include:  
• Better co-ordination of the training by universities for scientists through direct liaison 
with employers 
• Borderless progression of education – allow street-level entry and progression to 
‘consultant status’ as for the UK 
• Reintroduce more apprenticeship-oriented or vocationally-based traineeships  
• Improve the description of career pathways, starting with national standardisation of 
naming and job description (if not competencies) 
• Quarantine training positions through the application of relevant NPAAC standards 
• Regularise the TAFE-level training of technicians to fix the reported issue of variable 
fitness for purpose of those completing the courses 
• Better co-ordinate the education and training provided by scientific societies and those 
provided by educational institutions  
• Support the Academy of Science program promoting science in schools (namely, the 
Primary Connections – Linking Science with Literacy and the Science by Doing 
initiatives) and participate in the Australian Industry Group’s Adopt-a-School program 
which promotes linkages between industry and potential future workforce members 
• Change reward systems to recognise progressive education and training  
• Promote modular training in complementary disciplines, such as in pathology 
informatics 
• Support postgraduate education for the senior scientists 
• Provide in-service fellowships for advanced training (as WA has commenced) 
• Build closer links between universities and pathology laboratories 
• Lobby for the increase of profile of courses by moving them into health/medical 
faculties 
• Marketing and promotion especially using the preferred media of potential students, 
such as using Facebook and U-tube. 
 Pathologists 
Possible approaches include: 
• Increased lobbying of medical schools and other colleges for an appropriate level of 
teaching of pathology at the undergraduate level and assist with the development of  
science and case-based teaching modules – this helps with recruiting trainee 
pathologists and is also likely to improve the quality of use of pathology 
• Fund more training positions 




• Map training positions to need and make the opportunities well known 
• Link Fellowship training with regional medical schools to provide some continuous link 
with regional laboratories and incorporate rotation to main laboratories so as to prevent 
isolation and/or marginalisation for future career purposes 
• Promote further dual training for clinician-pathologists, such as happens now for 
haematologists, immunologists and geneticists, so as to increase cross discipline 
training and also patient contact, relevance and prestige – although this can have the 
opposite to the intended effect because trained pathologists can be lost from the 
laboratory to more clinical work 
• Provide in-service fellowships for advanced training and retraining ie genetics (as WA 
has commenced) 
• Build closer links between universities and pathology laboratories 
• Use of targeted marketing and promotion strategies, especially those using the preferred 
media of potential students such as using Facebook and U-tube. 
5.1.3 Improve recruitment 
Medical Scientists and Technicians 
Possible approaches include:  
• Improve the description of career pathways, starting with national standardisation of 
naming and job description (if not competencies) and promote the role of science and 
scientists in healthcare 
• Establish registration of medical scientists to increase prestige and recognise 
responsibility 
• Recognise scientist practitioners 
• Develop a program to attract disillusioned postgraduate researchers and provide 
bridging education 
• Encourage stronger connections and collaborations between pathology laboratory staff 
and research institutions 
• Recognise appropriate prior experience in a more vocationally-oriented training 
program 
• Expand work experience programs in laboratories 
• Establish indentured training programs for scientists 
• Use of targeted marketing and promotion strategies, especially those using the preferred 
media of potential students such as using Facebook and U-tube 
• Ensure competitive pay and reward systems. 





Possible approaches include: 
• Fund additional training positions 
• Recognise prior relevant experience, allowing cross-over from other areas of medicine - 
The College may need to review and refine its specialist development pathways so as to 
ensure that there are no unnnecessary barriers to entry and that the College is taking 
advantage of current national and international best practice in specialist training. 
• Promote the dual training for clinician-pathologists, such as happens now for 
haematologists, immunologists and geneticists, so as to increase cross discipline 
training and also patient contact, relevance and prestige –– although this can have the 
opposite to the intended effect because trained pathologists can be lost from the 
laboratory to more clinical work 
• Promote the role of pathology in pre-emptive and personalised medicine 
• Marketing and promotion strategies as outlined above. 
5.1.4 Retain those in the workforce longer 
Possible approaches include: 
• Ensure competitive pay and reward systems 
• Establish a career path that allows seniority for scientists as practitioners rather than 
managers 
• Give higher recognition to the value of scientists – which is being clearly demonstrated 
by the impact of a shortage 
• Increase the learning culture and establish mentoring programs for personal growth 
• Make more flexible the working conditions 
• Facilitate a ‘retirement leave and re-entry’ path, encouraging a longer working life 
• Give the opportunity to teach and mentor. 
5.1.5 Attract re-entry of those who have exited 
Possible approaches include: 
• Create more flexible working conditions – especially for collectors 
• Establish a set of attractive flexible employment conditions for those early in their 
retirement, including re-training into the field 
• Provide financial planning advice. 
5.1.6 Provide substitution from those outside the sector 
Possible approaches include: 
• Training of other specialists in specific sub-specialty and super-specialty areas of 
pathology (for example, ophthalmic surgeons in histopathology of the eye) and then 
support them through existing laboratories.  




5.2   Redistribute the existing workforce 
5.2.1 Geographically 
Possible approaches include: 
• Regional workforce development 
• Geographic-focused recruitment  
• Incentives based on location 
• Strengthening of formal and informal linkages to regional academic institutions. 
5.2.2 By discipline 
Possible approaches include: 
• Targeted programs to address the biggest gaps, such as those identified in:  
o Cytopathology 
o Forensic pathology 
o Molecular & cytogenetics 
o Toxicology. 




5.3   Improve the productivity of the workforce 
Industry restructuring with consolidation of laboratories and significant role substitution has 
already taken place but there are still opportunities for improvement. 
5.3.1 Improve work design 
Possible approaches include: 
• Exploring new roles with untrained entry-level workers 
• Expanded use of Point of Care Testing by clinicians 
• Substitution 
o More leveraging of professional roles according to identified competencies 
o Creation of “para-pathologist” and “para-scientist” roles 
• Clerical support for professionals to allow them to focus on high priority tasks 
• Centralisation 
o Specialised laboratories 
o Central review 
• Review of public sector pathology award structures 
• Removal of restrictions and constraints on progression 
• Consideration of the model that has developed with genetics. 
5.3.2 Introduce new technology 
Possible approaches include: 
• Informatics – exploring increasing use of: 
o Digital microscopy and telepathology 
o Voice recognition  
o Decision support, including knowledge management 
o Automation 
• Replacement of current testing with more direct molecular techniques, such as 
identification of bacteria in microbiology  
• Further development and adoption of Point of Care testing. 
5.3.3 Consolidate further 
Possible approaches include: 
• Centralisation of specialty laboratory services eg Cancer cytogenetics, Vic; Molecular – 
haemaglobinopathies, haematology, blood cancers, lysosomal disease. 




5.4 Reduce the demand 
5.4.1 Improve the quality of ordering 
It must be recognised that the application of these strategies may result in an increase in 
demand because evidence based guidelines often propose more pathology testing than current 
custom and practice ie the value of testing could be increased but potentially at a cost of 
increased workload. 
Possible approaches include: 
• Better teaching of the requesters at undergraduate and postgraduate levels 
• Development of “easier to adopt” requesting guidelines 
• Provision of electronic decision support with electronic request entry 
5.4.2 Rationing 
A possible approach includes the use of more rules in the Pathology Services Table. 




6 NEXT STEPS 
The following actions are seen as the most useful next steps to be undertaken in a 
comprehensive process of strategic engagement aimed at filling current information gaps and 
securing the participation with those organisations and individuals that have a stake in the 
development of appropriate strategies: 
• Invite comment from those consulted, in particular from the RCPA, scientific societies, 
industry groups and education providers, about the range of strategies proposed in this 
report and their relative priority. 
• Engage with the Australian Health Ministers’ Advisory Council and its relevant 
committees (including the National Health Workforce Taskforce Group). 
• Engage with other jurisdictional Departments that have a role in pathology workforce 
planning such as Attorneys General who have a role in forensic pathology. 
• Establish a national steering group and agree on the actions to be taken by prioritising 
the suggestions provided here, and any that may be prompted by review of the report, 
by assessing them against criteria of importance , ‘doability’, cost, impact and 
timeliness in order to draft a strategic plan for action.  
• Act on the outcome with a multi-pronged approach. 




APPENDIX A – CONSULTATIONS UNDERTAKEN 
• DoHA Diagnostic Services Branch 
o Ms Yvonne Korn, Assistant Secretary, Diagnostics and Technology 
o Ms Debbie Stanford, Director, Pathology (Quality) Section 
o Ms Pamela McKittrick, Assistant Director, Pathology Section 
o Ms Suzanne Petrie, Assistant Director, Pathology Section, NPAAC Secretariat 
o Mr Peter Murray 
• Royal College of Pathologists Australasia (RCPA) 
o Dr Debra Graves, CEO 
o Dr Tamsin Waterhouse, Deputy CEO 
o Dr Janney Wale, consumer representative 
• Australian Healthcare and Hospital Assoc Thinktank on Workforce 
• Professor Hal Swerrison, Dean Faculty of Health Science, Latrobe University,  
Discussion leader 
o 20 others 
• UK NHS Chief Scientist Prof Sue Hill - UK pathology workforce reform 
o Dr Beverly Rowbotham, President, RCPA 
o Dr Debra Graves, RCPA 
o Professor Leslie Burnett, Chair, NPAAC 
o Mr Mike Ralston, scientist 
o Dr Michael Whiley, Pathology Queensland 
o Assoc Prof Peter Stewart, RCPA QAP 
o Dr Geoff Fuller, rural pathology, NSW 
o Dr Tony Badrick, scientist 
o Dr Roger Wilson, President, NCOPP 
o Dr Janney Wale, consumer representative 
o Dr David Davies, ACHS pathology representative 
o Ms Penny Rogers, NCOPP 
o Professor Eva Raik, haematologist 
o Ms Megan Nelson, NATA 
o Dr Tamsin Waterhouse, RCPA 
o Associate Professor Ralph Green, RMIT 
• State-based Meetings 
o Canberra 
 Dr Peter Flett, WA Health 
 Professor Julia Potter, ACT Pathology 
 Dr Laurie Bott, Sonic Healthcare Pty Ltd 
 Dr Malcolm Mohr, pathologist 
 Dr Glenn Francis, Pathology Queensland 
 Mr Roger Killeen, consumer representative 
 Dr Michael Harrison, Chair, QUPC 
o Sydney 
 Mr Dennis Mok, ASM 
 Professor Eva Raik, Haematologist 
 Dr Renze Bais, AACB 
 Dr John Earle, AACB 
 Dr Roger Wilson, President, NCOPP 





 Associate Professor Ralph Green, Discipline of Laboratory Medicine, 
RMIT University 
 Dr David Thorburn, President, HGSA 
 Dr Surender Juneja, Haematologist  
 Professor Ruth Salem, Anatomical Pathologist  
 Dr Elizabeth Benson, Anatomical Pathologist 
o Brisbane 
 Ms Robyn Wells, Royal Brisbane Hospital, Scientist Haematology 
 Ms Jan Noble, CEO, AIMS 
 Dr Tony Badrick, Laboratory Manager, Sullivan and Nicolaides 
 Dr Michael Harrison, Chair QUPC, CEO Sullivan and Nicolaides 
Pathology 
 Dr Bev Rowbotham, Haematologist, President RCPA 
• Draft Report Review by Committees   
o Draft Report reviewed by the Quality Use of Pathology Committee at its 
meeting of August 214, 2008 and the comments incorporated 
o Draft Report reviewed by the Pathology Consultative Committee at its meeting 
of September 4, 2008 and the comments incorporated 
o Revised Draft Report reviewed by the National Pathology Accreditation 
Advisory Council at its meeting of September 11, 2008 and the comments 
incorporated 




APPENDIX B – REPORTS, PAPERS AND SUBMISSIONS 
• Australian Governments 
o COAG  
 COAG Productivity Commission 2005, Australia’s Health Workforce, 
Final report, Canberra See document: Productivity Commission 
Australia's Health Workforce.pdf 
o AHMAC National Health Workforce 
 Work Program - See document: AHMAC NHWT work program 2008-
09.pdf 
 Committee Structure - See document: AHMAC Workforce committee 
structure 2008.pdf 
 AMWAC The Specialist Pathology Workforce in Australia - Supply and 
Requirements 2003-2013 – 2003 - See document: AHMAC AMWAC 
The specialist pathology workforce in Australia.pdf 
 AHMAC Call for submissions on partially regulated professions - See 
document: AHMAC Call for submissions on partially regulated 
professions.pdf 
o Australian 
 DoHA The Australian Medical Workforce Aug 2001 See document: 
DoHA The Australian Medical Workforce Aug 2001.pdf 
o NHHRC submissions on Pathology Workforce 
 Pathology Associations Committee NHHRC submission on Workforce 
May 2008 - See document: PAC Pathology Asscoiations NHHRC 
submission on Workforce May 2008.pdf 
 RCPA NHHRC submission on Workforce May 2008 - See document: 
RCPA NHHRC submission on Workforce May 2008.pdf 
 RCPA NHHRC Submission on Genetic Testing May 2008 - See 
document: RCPA NHHRC Submission on Genetic Testing May 
2008.pdf  
 HISA NHHRC Submission on Workforce May 2008 - See document: 
HISA NHHRC Submission on Workforce May 2008.pdf 
 HGSA NHHRC submission May 2008 - See document: HGSA NHHRC 
submission May 2008.pdf 
 VCGS NHHRC submission May 2008 - See document: VCGS NHHRC 
submission May 2008.pdf 
o Pathology Section 
 QUPP 
• QUPC Pathology teaching in pre and vocational training - May 
2003 HMA - See document: QUPC Pathology teaching in pre 
and vocational training - May 2003 HMA.pdf 
• QUPC Undergraduate Pathology Teaching 2001 HMA - See 
document: QUPC Undergraduate Pathology Teaching 2001 
HMA.pdf 
• National Workshop on Quality and Safety in Pathology 
November 2007 - See document: National Workshop on Quality 
and Safety in Pathology.pdf 




• QUPC Workforce Issues Paper - See document: QUPC 
Workforce Issues Paper.pdf 
 NPAAC 
• NPAAC Pathology Workforce Census 2007 Pathologists July 
2008 - See document: NPAAC Pathology Workforce Census 
2007 Pathologists July 2008.pdf 
• NPAAC Pathology Workforce Projections July 2008 - See 
document: NPAAC Pathology Workforce Projections July 
2008.pdf 
• NPAAC Supervision Document 2007 - See document: NPAAC 
Supervision Document 2007.pdf 
o NHMRC 
 NHMRC Transforming Medicine Through Discovery NIH Pres Jan 2008 
Zerhouni - See document: NHMRC Transforming Medicine Through 
Discovery NIH Pres Jan 2008 Zerhouni.pdf 
o ABS 
 ABS 2006 Census by health occupation Feb 2008 - See document: ABS 
2006 Census by health occupation Feb 2008.pdf 
o AIHW 
 AIHW Australia's Health 2008, Chapter 8.2 Workforce - See document: 
AIHW Australia's Health 2008.pdf 
o To get 
 Bio-security Workforce & Surge Capacity 
 NHMRC Consumer study 
• NSW 
o NSW Health 2008, Pathology Workforce Forum, DLA Phillips Fox & David 
Dixon - See document: NSW Health Pathology Workforce Forum April 
2008.pdf 
• WA 
o WA The Defining Decade 2009-2016 Flett July 2008 - See document: WA The 
Defining Decade 2009-2016 Flett July 2008.pdf 
• Vic 
o Victorian DoH workforce survey of Scientists - Being undertaken 
• Australian Colleges & Scientific Societies 
o RCPA 
 RCPA Pathology Workforce Shortage Fact File July 08 - See document: 
RCPA Pathology Workforce Shortage Fact File July 08.pdf 
 RCPA The Impact of the Pathology Workforce Crisis on Acute 
Healthcare in Australasia - See document: RCPA The Impact of the 
Pathology Workforce Crisis on Acute Healthcare in Australasia.pdf 
 RCPA NZ Workforce Analysis Pathologists 2007 - See document: 
RCPA NZ Workforce Analysis Pathologists 2007.pdf 
 RCPA NHHRC submission on Workforce May 2008 - See document: 
RCPA NHHRC submission on Workforce May 2008.pdf 
 RCPA NHHRC Submission on Genetic Testing May 2008 - See 
document: RCPA NHHRC Submission on Genetic Testing May 
2008.pdf 




 RCPA Work Environment Survey August 2007 - See document: RCPA 
Work Environment Survey August 2007.pdf,  Summary - See document: 
RCPA Work Environment Survey August 2007 - Summary.pdf 
 RCPA Quality of pathology services Aug 2008.pdf - See document: 
RCPA Quality of pathology services Aug 2008.pdf 
o PAC 
 Pathology Associations Committee Meeting July 2008 - Draft Minutes - 
See document: PAC Pathology Associations Committee Meeting July 
2008 - Draft Minutes.pdf 
o AIMS 
 AIMS Submission on workforce Aug 2008.pdf - See document: AIMS 
Submission on workforce Aug 2008.pdf 
 AACB AIMS Is there a future for medical scientists and their 
associations - Badrick October 2006 - See document: AACB AIMS Is 
there a future for medical scientists and their associations - Badrick 
October 2006.pdf 
o AACB 
 AACB AIMS Is there a future for medical scientists and their 
associations - Badrick October 2006.pdf - See document: AACB AIMS 
Is there a future for medical scientists and their associations - Badrick 
October 2006.pdf 
o ASC 
 ASC Cytology Advanced Practitioner Summary Dec 2007 - See 
document: ASC Cytology Advanced Practitioner Summary Dec 
2007.pdf 
 ASC Submission on workforce Aug 2008 - See document: ASC 
Submission on workforce Aug 2008.pdf 
o HGSA 
 HGSA NHHRC submission May 2008 - See document: HGSA NHHRC 
submission May 2008.pdf 
 VCGS NHHRC submission May 2008 - See document: VCGS NHHRC 
submission May 2008.pdf 
o HISA 
 HISA NHHRC Submission on Workforce - See document: HISA 
NHHRC Submission on Workforce.pdf 
o AHHA 
 AHHA Think Tank on Workforce - Hal Swerrison LaTrobe - See 
document: AHHA Think Tank on Workforce - Hal Swerrison La Trobe 
July 2008.pdf 
• Education institutions 
o RMIT 
 RMIT Laboratory Medicine pathways 2008 - See document: RMIT 
Laboratory Medicine pathways 2008.pdf 
o La Trobe 
 AHHA Think Tank on Workforce - Hal Swerrison LaTrobe - See 
document: AHHA Think Tank on Workforce - Hal Swerrison La Trobe 
July 2008.pdf 
o Charles Sturt 




 Charles Sturt Uni The professional status of medical scientists in 
Australia 2003 McGregor & Moriarty - See document: Charles Sturt Uni 
The professional status of medical scientists in Australia.pdf 
• Other Australian 
 Standards Australia - Standards Used in the Australian Health Sector 
2003 - See document: Standards Australia - Standards Used in the 
Australian Health Sector 2003.pdf 
• Overseas 
o UK 
 UK NHS A High Quality Workforce Jul 2008 - See document: UK NHS 
A High Quality Workforce Jul 2008.pdf 
 UK NHS Career Framework for Scientists 2008 - See document: UK 
NHS Career Framework for Scientists 2008.pdf 
 UK NHS Modernising Scientific Careers flyer 2008 - See document: UK 
NHS Modernising Scientific Careers flyer 2008.pdf 
 UK NHS Standards for the Medical Laboratory Sep 2007 - See 
document: UK NHS Standards for the Medical Laboratory Sep 2007.pdf 
 RCPath Advanced practitioners in laboratory medicine informatics Jan 
2008 - See document: RCPath Advanced practitioners in laboratory 
medicine informatics Jan 2008.pdf 
o New Zealand 
 NZ Further Considerations Extended Role of Medical Laboratory 
Scientists Jul 2008 Legge - See document: NZ Further Considerations 
Extended Role of Medical Laboratory Scientists Jul 2008 Legge.pdf 
 NZ Extended Role of Medical Laboratory Scientists Jan 2008 Legge - 
See document: NZ Extended Role of Medical Laboratory Scientists Jan 
2008 Legge.pdf 
o Canada 
 Canada Pathology workforce issues Jun 2008 - See document: Canada 
Pathology workforce issues Jun 2008.pdf 
o US 
 US Strategic Challenges Facing Hospital Based Pathology - See 
document: US Strategic Challenges Facing Hospital Based 
Pathology.pdf 
• Underway 
o RCPA Medical School Survey to be conducted end 2008 
o Victorian DoH workforce survey of Scientists 
 
 
 
